With the LEAs, infertility is recognised as a condition to be treated. A functional change capable of guaranteeing a more equitable and inclusive access to ART procedures in all Italian regions, ensuring quality, safety and appropriateness of treatments and limiting interregional mobility and mobility abroad, to other European or non-European countries.
It is well known that the birth rate in our country has been constantly decreasing in recent years. But, according to the latest statistics presented in the 17th report of the Istituto Superiore di Sanità, 16,625 new births were registered during 2021 thanks to Assisted Reproductive Technology (ART) techniques, equivalent to 4.2% of the total births. The goal with LEA implementation is to reach 7% by 2025.
Antonino Guglielmino, founder of SIRU (Società Italiana della Riproduzione Umana, Italian Society of Human Reproduction), underlined: “With the LEAs, we have obtained the legitimation of care, which becomes a right for all couples who need it, in line with the rules and regulations of our National Health Service. This is the first step of a broader work involving the Regions”.
The year 2024 marks the tenth anniversary of the ruling of the Constitutional Court, which established the legitimacy of heterologous techniques but, despite the ten years that have elapsed, many couples still don’t know that they can follow this path in our country. “The entry into force of the LEAs must also be an opportunity to promote greater information on these issues, both locally and during the counseling carried out before the start of the journey”, pointed out Walter Vegetti, Head of the Centro di Procreazione Medicalmente Assistita of the Fondazione Cà Granda Ospedale Policlinico in Milan.
IBSA Italy confirms its commitment aimed at simplifying the ART process, appropriately informing and facilitating the relationship between specialists and couples, thus guaranteeing a more inclusive path to ART procedures in all Italian regions, limiting inter-regional mobility and mobility abroad and, most importantly, ensuring the quality, safety and appropriateness of treatments.